- Home
- GLAD vs DNA Comparison
GLAD vs DNA Comparison
Compare GLAD & DNA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GLAD
- DNA
- Stock Information
- Founded
- GLAD 2001
- DNA 2008
- Country
- GLAD United States
- DNA United States
- Employees
- GLAD N/A
- DNA N/A
- Industry
- GLAD Finance/Investors Services
- DNA Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- GLAD Finance
- DNA Health Care
- Exchange
- GLAD Nasdaq
- DNA Nasdaq
- Market Cap
- GLAD 644.5M
- DNA 562.1M
- IPO Year
- GLAD N/A
- DNA N/A
- Fundamental
- Price
- GLAD $30.26
- DNA $11.52
- Analyst Decision
- GLAD Hold
- DNA Hold
- Analyst Count
- GLAD 1
- DNA 6
- Target Price
- GLAD $23.00
- DNA $37.80
- AVG Volume (30 Days)
- GLAD 119.0K
- DNA 1.3M
- Earning Date
- GLAD 02-11-2025
- DNA 02-27-2025
- Dividend Yield
- GLAD 6.57%
- DNA N/A
- EPS Growth
- GLAD 89.73
- DNA N/A
- EPS
- GLAD 4.34
- DNA N/A
- Revenue
- GLAD $96,621,000.00
- DNA $217,951,000.00
- Revenue This Year
- GLAD $3.67
- DNA N/A
- Revenue Next Year
- GLAD $14.13
- DNA N/A
- P/E Ratio
- GLAD $6.97
- DNA N/A
- Revenue Growth
- GLAD 11.79
- DNA N/A
- 52 Week Low
- GLAD $19.20
- DNA $5.26
- 52 Week High
- GLAD $30.24
- DNA $64.40
- Technical
- Relative Strength Index (RSI)
- GLAD 71.86
- DNA 60.05
- Support Level
- GLAD $27.29
- DNA $8.44
- Resistance Level
- GLAD $29.48
- DNA $12.75
- Average True Range (ATR)
- GLAD 0.60
- DNA 1.11
- MACD
- GLAD 0.10
- DNA 0.03
- Stochastic Oscillator
- GLAD 98.67
- DNA 71.46
About GLAD Gladstone Capital Corporation
Gladstone Capital Corp is an externally managed, closed-end, non-diversified management investment company. Its investment objectives are to, achieve and grow current income by investing in debt securities of established businesses that would provide stable earnings and cash flow to pay expenses, make principal and interest payments on its outstanding indebtedness, and make distributions to stockholders that grow over time; and provide its stockholders with long-term capital appreciation in the value of its assets by investing in equity securities of established businesses that can grow over time to permit it to sell its equity investments for capital gains.
About DNA Ginkgo Bioworks Holdings Inc.
Ginkgo Bioworks Holdings Inc is the platform for cell programming, providing flexible, end-to-end services that solve challenges for organizations across diverse markets, from food and agriculture to pharmaceuticals to industrial and specialty chemicals. The Company reorganized its operations into two operating and reportable segments: Cell Engineering and BiosecurityThe majority of revenue in the company comes from the Biosecurity segment, which charges fees for data analytics and services.